Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase1, Recruiting
A Prospective Natural History Study of Lymphatic Anomalies
for
Lymphatic Diseases, Lymphatic Abnormalities
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: All
Age: 0 - 70+
Code: NCT05731141
Recruiting
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
for
Acute Ovarian Failure, Infertility,
Location: Bethesda MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: Female
Age: 4 - 35
Code: NCT05440617
Recruiting
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
for
NSCLC Stage IV, ALK Fusion Protein Expression
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT05950139
Phase1, Phase2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Optimal Pacing Rate for Cardiac Resynchronization Therapy
for
Atrial Fibrillation, Persistent
Location: Clinton MD, Washington DC, Fairfax VA
Sponsor: Medstar Health Research Institute
Sex: All
Age: 18 - 70+
Code: NCT06445439
Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Mineola NY, New York NY, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase1, Phase2, Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
for
Kidney Transplant
Location: Boston MA, New Haven CT, Philadelphia PA, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05917522
Phase2, Recruiting
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
for
Small-cell Lung Cancer, Small Cell Lung Carcinoma
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT05450965
Phase2, Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
for
Heart Diseases, Coronary Artery Disease,
Location: St. John's, Saint John, Providence RI, Hartford CT,
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18+
Code: NCT04124120
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: St. John's, Trois-Rivieres, Montreal, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Boston MA, Quebec, New York NY, Bethesda MD,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
for
Pancreatic Cancer, Renal Cell Cancer, Breast Cancer, Melanoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT02830724
Phase1, Phase2, Recruiting
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
for
Arrhythmogenic Right Ventricular Cardiomyopathy
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Tenaya Therapeutics
Sex: All
Age: 18 - 65
Code: NCT06228924
Phase1, Recruiting
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
for
Substance Use Disorder, Alcohol Use Disorder
Location: Baltimore MD
Sponsor: National Institute on Drug Abuse (NIDA)
Sex: All
Age: 18 - 70+
Code: NCT06552741
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
for
Overactive Bladder, Urinary Urgency Incontinence,
Location: New York NY, Bala-Cynwyd PA, Annapolis MD,
Sponsor: Axonics, Inc.
Sex: Male
Age: 18+
Code: NCT06511141
Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase1, Phase2, Recruiting
Viral Load in Blood and Lymph Tissues in People Living With HIV
for
HIV
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT00001316
Recruiting
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
for
Metastic Thyroid Cancer
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT04927416
Phase2, Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
for
Movement Disorders, Neurology, Parkinsons Disease
Location: New York NY, Philadelphia PA, Baltimore MD, Dallas TX